What is Jefferies's price target for DGX?

Jefferies's latest stated price target for Quest Diagnostics Incorporated (DGX) is $185, from its action on Dec 10, 2024.

What is Jefferies's rating on DGX?

Jefferies rates DGX Buy, a bullish rating, as of Dec 10, 2024.

When did Jefferies last change its view on DGX?

On Dec 10, 2024, Jefferies resumes coverage at Buy, price target $175 to $185.

Analyst firms · Jefferies · DGX

Jefferies DGX price target and rating history

Quest Diagnostics Incorporated (DGX) · Health Care

Jefferies rates Quest Diagnostics Incorporated (DGX) Buy with a $185 price target, as of its latest action on Dec 10, 2024. It has published 3 rating actions on DGX since February 2022, including 1 upgrade and 1 downgrade.

Current rating: Buy
Price target: $185
Median target, all firms: Too few
Actions on DGX: 3

Jefferies price target on DGX

Jefferies price target on DGX, each point a stated target, February 2022 to December 2024.

Every Jefferies rating on DGX

Dec 10, 2024
ResumeJefferies resumes coverage at Buy, price target $175 to $185
Feb 7, 2024
UpgradeJefferies upgrades to Buy from Hold, price target $140 to $155
Feb 2, 2022
DowngradeJefferies downgrades to Hold from Buy, price target $135

Questions about Jefferies and DGX

What is Jefferies's price target for DGX?: Jefferies's latest stated price target for Quest Diagnostics Incorporated (DGX) is $185, from its action on Dec 10, 2024.
What is Jefferies's rating on DGX?: Jefferies rates DGX Buy, a bullish rating, as of Dec 10, 2024.
When did Jefferies last change its view on DGX?: On Dec 10, 2024, Jefferies resumes coverage at Buy, price target $175 to $185.

More DGX rating histories

All Jefferies ratings DGX news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.